The junior-listed AIM index climbs 0.2 percent to outperform the FTSE Small Cap index, up 0.1 percent, but lag a 0.3-percent rise in the mid-caps index. Eckoh, a provider of customer service and secure payment solutions, jumps almost 13 percent after securing a 10-year contract worth a min
Read moreJunior-listed AIM shares trade flat, outperforming the FTSE Small Cap index, off 0.3 percent, and the mid-caps, 0.6 percent weaker. Ultrasis, a provider of cognitive behavioural therapy for stress and depression, jumps 7.1 percent after its U.S. joint venture wins a contract with Mental Hea
Read moreUltrasis has agreed to buy Screenetics, a health services provider, for up to 4.8 million pounds. The healthcare company will initially pay £570,600 in cash plus shares worth £380,000 for Screenetics, with a further payment of up to £3.85m depending on the target's performance after the acquisition
Read moreUltrasis, which develops interactive health care programmes, announced John Smith as its news Chief Executive Officer (CEO). The appointment is effective immediately. Smith had already assumed the role of Interim Chief Executive in June of this year, having previously been its Marketing Director
Read moreUK small caps drop 1.4 percent and junior-listed AIM shares shed 0.7 percent, mirroring weakness on the wider market, with the blue chip off 0.8 percent and the midcaps 0.9 percent weaker. Industrial and construction metals manufacturer Fiberweb jumps 7.4 percent in brisk trade after it re
Read moreShares in AIM-listed interactive healthcare products provider Ultrasis rose sharply on Monday morning after the company unveiled a regulatory success for its US joint venture. The company reported that its computerised product for treating anxiety and depression, Beating the Blues, had been include
Read more